RESUMO
COVID19 pandemic is pushing business organizations to cope in newer, more resilient ways. In this study, in-depth qualitative research was conducted using Weick's sensemaking framework (1995) to give organizational leaders a snapshot of how individuals grappled with sensemaking during this time. The enactment of sensemaking for individuals occurred based on four major COVIDian realities: life during the lockdown, work from home, moments of reflection, and struggles and emotions. The implications of the findings are two folds. First, the dynamic nature of extracted cues coupled with greater technology use increased enactment frequency amongst individuals leading to a collapse in sensemaking. Secondly, we propose that this collapse has a significant impact on human cognition, which will further affect the nature of work as well as the meaning of work in life.
RESUMO
OBJECTIVE: To describe a patient with hypercalcemia due to multiple myeloma and an associated atrial plasmacytoma. METHODS: A case report is presented with clinical and laboratory findings. We review the differential diagnosis of hypercalcemia and discuss multiple myeloma and plasmacytomas. RESULTS: A 48-year-old woman presented to the emergency department with lethargy after sustaining trauma to the head. She was found to have a subdural hematoma and a parietal intraparenchymal hemorrhage. She had a serum calcium level of 17.2 mg/dL (normal, 8.4 to 10.6), anemia, thrombocytopenia, and renal insufficiency. Serum protein electrophoresis revealed a monoclonal gammopathy, and a bone marrow biopsy specimen was consistent with multiple myeloma. The patient required surgical evacuation of her subdural hematoma. Postoperatively, multiple complications developed, including a supraventricular tachycardia. She did not regain consciousness, and ventilatory support was withdrawn. On autopsy, she was found to have disseminated myeloma and an atrial plasmacytoma. CONCLUSION: This case report emphasizes the need to consider a plasmacytoma as a manifestation of multiple myeloma when localizing symptoms are present.
